FDA Warning Letter — Sunrise Pharmaceutical, Inc.
The FDA took a Warning Letter action against Sunrise Pharmaceutical, Inc. on January 14, 2010 (Rahway, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Sunrise Pharmaceutical, Inc.
- Date
- January 14, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Center
- CDER
- Location
- Rahway, NJ (United States)